Comparing side effects of prostate cancer treatments
Prostate cancer is the most common cancer for men in the United States. Luckily, most men with prostate cancer will still be alive 15...
Prostate cancer is the second-leading cancer among men. Here’s what to know about it
Cancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in the United States in...
Special drug pricing program helps prostate cancer patients stick to their treatment
Patients with advanced prostate cancer being treated at hospitals participating in a special drug pricing program are more likely to keep up with their...
A leap forward in prostate cancer treatment: the promise of relugolix
In the world of cancer treatment, finding therapies that are both effective and come with fewer side effects is a constant goal. A recent...
Back pain and prostate cancer may have a strong connection
Back pain is a common complaint among adults, often attributed to causes like poor posture, strain, or age-related changes in the spine. However, when...
5 things to know about prostate enlargement and treatment options
Prostate enlargement is a common condition associated with the natural aging process in men, affecting half of men between the ages of 70 to 79...
AI can help predict liver cancer risk
A team from UC Davis Health is pioneering the use of machine learning to predict liver cancer risk more accurately.
Their new work focuses on...
Back pain and prostate cancer: What is the connection?
When we think of back pain, we often associate it with common causes like muscle strain, poor posture, or spinal issues.
However, what many might...
A big breakthrough in prostate cancer treatment
In the quest to combat prostate cancer, researchers from the University of Michigan Rogel Cancer Center have made a significant discovery.
The team, led by...
Combo therapy could treat prostate cancer better
Researchers at UC San Francisco have made a significant breakthrough in treating prostate cancer relapses.
In a comprehensive Phase 3 clinical trial, they discovered that...